By MRI analysis of GBM patients, Nishikawa et al. observed that highly invasive tumors were correlated with low VEGF expression in the tumor periphery, an area with high expression of CD44 associated with the invasive phenotype of GSCs [112]. The gene discussed is CD44; the disease is glioblastoma.